Zoetis Inc. (ZTS)
Pharmaceutical Preparations · Healthcare · $33.3B
Intrinsic Value (Consensus)
$119.74
Current Price
$79.33
Margin of Safety
+50.9%
50.9% Below Intrinsic Value
Value: $120
Price: $79
Valuation Model Estimates
Current Price: $79.33
DCF (Discounted Cash Flow)
$123.45
Graham Number
$32.76
Earnings Power Value
$58.45
Relative Value (P/E)
$120.40
Dividend Discount Model
$176.67
Consensus Value
$119.74
Model Assumptions
Discount Rate
10.3%
Growth Rate
10.1%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
B
72
Profitability
25/25
Strength
12/25
Valuation
22/25
Growth
13/25
Financial Health Signals
Very high debt — Debt/Equity ratio is 271% (above 200% is risky)
Strong profitability — ROE of 80% (above 20% is excellent)
Key Financials
- EPS (TTM)
- $6.02
- EPS (Forward)
- $6.63
- Book Value
- $7.92
- P/E Ratio
- 20.0
- Forward P/E
- 18.2
- PEG Ratio
- —
- ROE
- 80.2%
- Debt/Equity
- 271%
- Revenue Growth
- 2.3%
- Earnings Growth
- 10.1%
- Dividend Yield
- 0.4%
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance